Press Release: Selcia : Identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity, published in The Journal of Medicinal Chemistry

Discovery follows successful collaboration between Selcia, Cypralis and Gilead SciencesCambridge and Ongar, UK, 17th September 2018 / Sciad Newswire / A paper entitled 'Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle' by authors from Selcia, Cypralis and Gilead has been selected as a featured article by the editors of The Journal of Medicinal Chemistry.